chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 5 year old male patient with a history of adenoidectomy who was vaccinated with a dose of VARIVAX (Merck) on 10-JUN-2005 and 15-MAY-2009. On 16-FEB-2010 the patient developed a moderate case of chickenpox. It was reported that the patient had a few scars from the chickenpox. The patient sought medical attention by an office visit. On an unknown date the patient recovered from chickenpox. The outcome of scars from the chickenpox was unknown. Follow up information has been received from a physician who indicated that the child with no illness at the time of vaccination, no pre-existing allergies, no birth defects and no medical conditions had not been vaccinated in her office. On 16-FEB-2010 the patient came to her office with rash that was typical of chickenpox. On an unknown date the patient recovered from chickenpox. No laboratory or diagnostic studies were performed. Additional information is not expected.
Patient received her 1st dose of Moderna vaccine and had facial swelling and trouble breathing around 2 hours later. She was advised to go to the ER and was sent home and told to take benadryl. I advised on her on the correct dosing of benadryl and told her to go back to the ER if her symptoms worsened.
Patient came to MD's office on 3/21/16 and presented with fever and swelling & redness at injection site. Parents stated fever started on 3/20/16.
Multiple lymph nodes in both arm pits are extremely swollen, tender, stinging feeling, and red. Symptoms worsened over 5 days then lessened over five days. I the 3 months since 1st dose with each menstruation cycle lymph nodes in both arm pits swell, become tender with stinging feeling, and red while menstruating.
6PM pt starting screaming bloody murder; mom could not get pt to stop screaming so called MD; MD advised mom take pt to ER; pt turned blue & required shaking to start breathing again according to mom; Enroute to ER pt cont to gasp for air;
AT AGE 3YR TO 5YR CORE SYMPTOMS: CONTINUOUS SCREAMING TO COMMUNICATE -NON VERBAL WITH WORDS, ECHOLITHC, SLOWED DEVELOPEMENT IN SPEECH AND MOTOR SKILLS,UNABLE TO EXPRESS EMOTION (excited,happy,sad etc.,)AND UNCONTROLLED ANGER.SERVERAL TEST WERE RAN BY A NEUOROLIST, PSYCOLOGIST AND DOCTOR-HE WAS ALSO TESTED THROUGH SCHOOL PSYCOLOGIST  AND SPECIALIST-WITH COMBINE RESULTS FROM SCHOOL AND PERSONAL TESTING IT WAS DETERMINE PATIENT IS AUTISTIC AND HAS ADHD** ALSO A VACCINE CALLED PREVNAR WAS GIVEN IN 9-12-03 1TIME  9/26/08 MR received from parent including psych evals and care plans. Eval 10/29/2003 (+) for developmental delays in cognitive and verbal abilities. Psych eval 1/14/2006 which report sleep disturbances and ADHD. Neuropsych eval 6/6/06 with sx suggestive of Pervasive Developmental Delay and Autism. School eval with DX: Communication d/o 2' to Autism Spectrum Disorder. MR received from PCP. 1st visit 3/13/2001 with normal growth and dev.  Exam (+) for ezcema and congestion. Rocking behavior noted 12/3/02. Speech noted to be delayed at 4yr check 9/9/03.  1/27/2010 Follow-up: As of date, my child still experiences mental disfunctions and abnormalities.
CDC reports: 3 mo infant developed fever to 102, local rxn @ inject site, rash & screaming episode following DTP/OPV immunization. Duration of illness 4 days.
pt recv vax;rt shoulder edematous/erythematous;known to have fallen on arm p/ immun;examined by MD;to have mild cellulitis x 7 days;mom instructed to RTC if condition worsens; shows no sign of improvement;
Patient received the high-dose flu shot and Prevnar on the same day and requested them in the same arm.  She came back on 11/12/15 because her arm near her elbow (not where she was vaccinated) was swollen slightly, red, and warm to the touch.
Initial misuse report received from a healthcare professional on 26 September 2013. The case was received on 21 March 2014. The patient had received two doses of FLUZONE HD in 10 days. No adverse event was reported. List of documents held by sender: none.
I got the booster in September and in January I was tested for COVID-19 at home, I contracted from a party. I had a light floating feeling the next day and was like I was out of my body, and it was positive. I went to immediate care to get a medical test and it was positive. Fortunately, it was light duty with four days of light coughing, nasal issues and fatigue. I was only for days. My health care provider had a prescription for me but not PAXLOVID, it started with an I. It worked really great.
Patient presented to the ED and was subsequently hospitalized for acute congestive heart failure, atrial fibrillation within 6 weeks of receiving covid vaccination.
No adverse effects; A patient was administered a dose of improperly stored VARIVAX; This spontaneous report was received from the medical assistant, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported.   On an unknown date, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) lot # S005084, expiration date 19-FEB-2021, for prophylaxis (strength, dose, route and frequency were not reported).  The temperature excursion range was of -14 Centigrade degrees (°C) to -10°C (-14.4°C), during 18 minutes. A previous temperature excursion was not reported. A digital data logger was involved due to a calibration. No adverse effects were reported.
Information was received on 13-MAR-2017 from an elderly male patient. Medical history/concurrent conditions included hypothyroidism, overactive bladder, and allergy to unspecified medication for overactive bladder. Concomitant medications were reported as unspecified thyroid medication. The patient reported that back in 1996, he developed a "severe case of the shingles". Then in 2007, he received the ZOSTAVAX vaccine, which is other then indicated in the prescribing information. On an unspecified date, the patient developed a rash and a spike in his temperature. He then started to develop severe chest and back pain and would be woken from deep sleep because of the pains. He was prescribes various medications that did not help him. When asked if he sought medical attention- he replayed "yes: talked with physician."The patient has suffered with these adverse events from about 20-21 months, however the patient stated that the past 2-3 months, the pain has been worse. He also stated that he was recently diagnosed with post-neuralgia. The patient's current status is not recovered. No further adverse event information was provided.  Additional information has been requested.
shingles rash on the right side near the backbone; shingles rash on the right side near the backbone; she has been taking acetaminophen for the pain; she has been taking acetaminophen for the pain; she received the first dose of the Shingrix and received second dose of the Shingrix vaccine in her left arm on 03/12/2019; This case was reported by a consumer and described the occurrence of vaccination failure in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included herpes zoster (herpes near her nose and using the acyclovir topical formulation prescribed to treat that shingles.).   On 22nd June 2018, the patient received the 1st dose of Shingrix. On 12th March 2019, the patient received the 2nd dose of Shingrix. In March 2020, not applicable after receiving Shingrix, unknown after receiving Shingrix and an unknown time after starting Zovirax and Acetaminophen, the patient experienced drug dose administration interval too long. On 17th March 2020, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, rash and pain. The patient was treated with acyclovir (Zovirax) and paracetamol (Acetaminophen). On an unknown date, the outcome of the vaccination failure, shingles, rash, pain and drug dose administration interval too long were unknown.   It was unknown if the reporter considered the vaccination failure, shingles, rash and pain to be related to Shingrix and Shingrix.  Additional details were reported as follows: The patient received the 2nd dose of the Shingrix vaccine on 12th March 2019 and 1st vaccine on 22nd June 2018, later than the recommended schedule, which led to lengthening of the vaccination schedule. The patient experienced shingles rash on the right side near the backbone on 17th March, two days before date of reporting. She had been applying acyclovir topically and taking acetaminophen for the pain.  She had not been seen her doctor yet and as she was hesitant to go and see her doctor because of the Covid-19 incidences in her area.  She had shingles with no blister but just a rash with severe pain. The reporter contented to follow up with HCP. This case was considered as suspected vaccination failure as details regarding laboratory confirmation were unknown at the time of reporting.
Soreness at injection site.  Full-body myalgias, arthralgias starting 9 hours after injection; Fever to 100.1 on the morning following injection.
VACCINE ADMINISTERED (02/07/2022), THE DAY AFTER BEYOND USE DATE (02/06/2022).
This spontaneous report as received from a health care worker refers to an unknown number of patients with unknown demographics. Approximately on an unknown date in the year 2014, unknown number of GARDASIL vaccines undergone temperature excursion and improperly stored which had been administered to an unknown number of patients. No adverse effects were reported. No additional information was provided. No product quality complaint was involved. Additional information has been requested.
A magnet was   placed on the area where I was given my vaccine (Moderna) and it stayed "magnetized" for  three hours.  The magnet stayed in place for that time. I  have heard that happening to  others, I then decided to  try it myself. I was amazed  that my arm seemed magnetized!
5cm induration, 2cm erythema right anterior thigh. Fever, tremors at site of IPV.
redness and swelling, with diagnosis MSSA abscess near site of injection requiring incision and drainage approximately 15 days after vaccine
5-10 minutes after I received the vaccine I had a headache. At first it wasn't bad, however, that afternoon it worsened and did not improve with Tylenol or Advil. The next day was worse than the first because the headache became very bad and I was unable to do anything besides rest on the sofa. The following day I felt somewhat better but the headache persisted along with eye irritation, burning, and pain. That continued for 2 more days. My headache worsened on Tuesday, February 16. I awoke with a pounding headache in the back of my head. It caused me to become nauseous for several hours which improved by the afternoon.I've have never had a migraine but think that's what this was.  I rested the entire day. Today, Wednesday, February 17, I awoke with a mild headache which worsened during the day. Along with this my eyes ached and I noticed reading words and numbers was difficult because they were blurry. I decided to hold off on taking any pain medication to see whether or not the headache would calm down and it hasn't; it tends to move around my head during the day. Hopefully, the Tylenol will help today.
Next morning had unwell feeling took 3 advil was fine around 4:30 pm same day 3/24 felt unwell again took 3 advil felt better again. Next morning 3/25 woke up at 4 am had pain and swelling in left arm pit took 3 advil no change. On 3/27 still had swelling and pain. Went to Dr and they gave me a prednisone shot and pills to follow for next several days and told to notify vaccine clinic.
Complete loss of hearing, dizziness, headaches, vision comes and goes, has been to 3 emergency rooms, was prescribed steroids, injected steroids into ear by healthcare professional.
felt very unwell; discomfort; dizziness; Nausea; This is a spontaneous report from a contactable consumer (patient) reporting herself. A 52-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number-UNKNOWN) via an unspecified route of administration in left arm on 07Apr2021 as dose 1, single (at the age of 52 years-old) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that, on an unspecified date after the first dose, the patient experienced felt very unwell, discomfort, dizziness, nausea. Upon follow-up (04Aug2021); patient stated she got her first shot in April, but never got the second shot. She doesn't remember the anatomical location she received her first dose in, but she thinks it was in her left arm. She would like to know, since it has been so long since her first dose, if she has to start with the vaccination series from scratch. Clinical outcome of the events was unknown at the time of report.  Follow-up attempts are completed. No further information is expected.
Approximately 8 hrs after receiving pneumococcal adult vaccine, pt states experienced red, hard, swollen, lump-several inches in diameter, L upper arm; also experiencing bruising, soreness/tender, some erythema crossing the elbow; treatment included Motrin or Tylenol for discomfort, moist compress, Keflex.
About 30 minutes after receiving my injection on Thursday, I noticed my upper lip felt like it was swelling.  Over the next 30 minutes, I felt the same in my lower lip and cheeks.  I took 50 mg of Benadryl at that time.  I slept for nearly 20 hours after that.  On Friday, I experienced severe body aches from head to toe.  I felt somewhat better Saturday.  I woke up Sunday with nausea and dizziness that lasted all day and evening.  I woke up feeling better Monday morning but noticed 2 enlarged lymph nodes above my collar bone and pain from my R deltoid, across my shoulder and into my lower neck.  It is Tuesday and and the lymph nodes are painful to touch and I'm experiencing 5/10 pain in my upper arm, shoulder R side and back of neck and above my R scapula.  I am considering calling my PCP.
Initial report received from a health care professional (nurse) on 29 Sep 2010: On 01 Sep 2010, this child was vaccinated with only the MenCWY liquid conjugate component of MENVEO, (batch number not reported), (dose unknown) without being reconstituted with the MenA conjugate component. On an unspecified date, the child was revaccinated with the full dose of MENVEO.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On or about 01-JAN-2015, the patient was inoculated with ZOSTAVAX at a clinic for routine health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. On or about 01-MAR-2016, the patient was treated by a Nurse Practitioner for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcomes of the events were unknown at the time of reporting. Causality assessment was related. Additional information has been requested.
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 01-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.).    No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022.   This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow-up; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704416:Master case
606 doses were given after expiration date; Vaccine stored in refrigerator on 27-Nov-2021, expired product on 13-Oct-2021 and administered on 01-Dec-2021; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 27-Nov-2021, expired product on 13-Oct-2021 and administered on 01-Dec-2021) and EXPIRED PRODUCT ADMINISTERED (601 doses were given after expiration date) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Dec-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Nov-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 27-Nov-2021, expired product on 13-Oct-2021 and administered on 01-Dec-2021). On 01-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (601 doses were given after expiration date). At the time of the report, PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 27-Nov-2021, expired product on 13-Oct-2021 and administered on 01-Dec-2021) and EXPIRED PRODUCT ADMINISTERED (601 doses were given after expiration date) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. The reporter stated that initially there were 606 doses from expired lot and they found out later that some patients that were impacted had received the Janssen COVID-19 vaccine. Date the vial placed in refrigerator was on 27-Nov-2021. There was no temperature excursion. The patient had no adverse event. No Treatment information was reported.
Information has been received from a physician concerning a 5 year old female who on approximately 04-JUN-2007 was vaccinated with the second dose of PROQUAD. The first dose was given when the patient was 12 months old. About a week ago (on approximately 18-JUN-2007), the patient experienced "severe cellulitis on her upper thigh approximately two weeks after receiving PROQUAD. The patient sought unspecified medical attention. Additional information has been requested.
Starting 07/22/2022, in the morning, I had a sore throat, nasal congestion, low grade fever and chills. I tested myself with an at-home COVID-19 test on 07/23/2022 which was negative. I went the same day to the pharmacy to get tested and the PCR test came back positive on 07/24/2022. I called my doctor and they prescribed me a 5 day course of prednisone. They didn't think I was sick enough for PAXLOVID. The fever lasted for a few more days then stopped. The sneezing basically stopped within a day of taking the prednisone. The past couple of days I have felt pretty much normal except some slight fatigue. I have had no real respiratory symptoms.
The vials were moved from freezer to refrigerated conditions on 28-Dec-2021; Moderna COVID-19 vaccine expired doses were administered to patients after the manufacturer date of expiry.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine expired doses were administered to patients after the manufacturer date of expiry.) and PRODUCT STORAGE ERROR (The vials were moved from freezer to refrigerated conditions on 28-Dec-2021) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032F21A) for COVID-19 prophylaxis.     It was unknown if patient had acute illnesses at the time of vaccination and up to one month before.It was unknown  if patient had ever been diagnosed with/ tested positive for COVID-19.It was unknown if patient had chronic or long-standing health conditions.  Concurrent medical conditions included Penicillin allergy. Concomitant products included FOLIC ACID, PANCREATIN (CREON), MULTIVITAMIN [VITAMINS NOS] and PANTOPRAZOLE for an unknown indication.    On 08-Feb-2022 at 3:54 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 08-Feb-2022 at 3:54 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine expired doses were administered to patients after the manufacturer date of expiry.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vials were moved from freezer to refrigerated conditions on 28-Dec-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna COVID-19 vaccine expired doses were administered to patients after the manufacturer date of expiry.) and PRODUCT STORAGE ERROR (The vials were moved from freezer to refrigerated conditions on 28-Dec-2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   HCP reported that five Moderna COVID-19 vaccine expired doses were administered which was a mix of doses for those patients.  No  temperature excursions was reported.  On 08-Feb-2022 2 doses were administered to 2 individual patients. The vial was moved from freezer to refrigerator on 28-DEC-2021.  No treatment medication were provided.
Information has been received from a 69 year old female with no allergy who in June 2008, was vaccinated with ZOSTAVAX 0.65 ml (lot # not provided). Concomitant therapy included Metoprolol, Crestor, Actonel. In June 2008, within couple days, the patient experienced rash at injection site and headache after vaccination. The patient's rash at injection site and headache persisted. The patient sought medical attention. Additional information has been requested.
Chest pain on 12/25/2022 early am - felt increasingly better as day went on and taking advil Chest pain on 1/5/2023 evening around 9:45pm.  Saw nurse practioner in my practice on 1/6 - prescribed naproxen for the pain. Shortness of breath and pain continuing by 1/9/2023 - saw primary care physician same day - ordered D-Dimer test and CT scan of chest for 1/10/2023
Initial report received from health care professional on 04 Dec 2009: This patient (under the age of 4 years) was vaccinated with FLUVIRIN 0.50 ml, intramuscular, on 04 Dec 2009. No adverse effect were noted after administration.